SCHEMBL24787182

SCHEMBL24787182

O=C(O)c1ncc(O)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.36
CA1 P00915 3/20 0.36
CA2 P00918 3/20 0.36
CA7 P43166 3/20 0.36
CA9 Q16790 3/20 0.36
CA14 Q9ULX7 3/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA3 P07451 1/20 0.36
TYR P14679 1/20 0.36
DRD1 P21728 1/20 0.36
CA5A P35218 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
HCAR2 Q8TDS4 4/20 0.36
KDM4E B2RXH2 4/20 0.36
P4HA1 P13674 2/20 0.36
P4HTM Q9NXG6 2/20 0.36
NAPRT Q6XQN6 2/20 0.36
ALDH1A1 P00352 4/20 0.35
HSD17B10 Q99714 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3705899 0.78 ALDH1A1 (0.54) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL361106 0.76 KDM4E (0.52) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL3695695 0.76 GABRP (0.41) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL10328694 0.76 HCAR2 (0.41) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL18520707 0.76 TPMT (0.39) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL6873117 0.76 HCAR2 (0.37) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL9852803 0.76 APLNR (0.45) HCAR2KDM4EALDH1A1HSD17B10ALOX15
SCHEMBL286703 0.76 HCAR2 (0.41) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL20929049 0.76 HCAR2 (0.34) HCAR2KDM4EP4HA1P4HTMNAPRT
SCHEMBL30526873 0.74 NPC1 (0.43) KDM4EP4HA1P4HTMALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103880757-B A kind of synthetic method of 5-hydroxy pyrimidine-2-carboxylic acid SHANGHAI BEPHARM CO., LTD. (CN) 2016-02-24 CN claimed
CN-103880757-A Synthesis method for 5-hydroxyl pyrimidine-2-carboxylic acid BIDE PHARMATECH LTD 2014-06-25 CN claimed
US-20260001994-A1 HIGH-MOLECULAR COMPOUND, MOLDING COMPOSITION, FILM AND CAPACITOR PANASONIC IP MAN CO LTD (JP) 2026-01-01 US disclosed
CN-119110816-A Polymer compound, molding composition, film, and capacitor 松下知识产权经营株式会社 2024-12-10 CN disclosed
WO-2023248874-A1 POLYMER COMPOUND, COMPOSITION FOR MOLDING, FILM AND CAPACITOR パナソニックIPマネジメント株式会社 2023-12-28 WO disclosed
US-20220399166-A1 DIELECTRIC COMPOSITION, DIELECTRIC FILM, AND CAPACITOR PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2022-12-15 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-103880757-B A kind of synthetic method of 5-hydroxy pyrimidine-2-carboxylic acid SHANGHAI BEPHARM CO., LTD. (CN) 2016-02-24 CN disclosed
CN-103880757-B A kind of synthetic method of 5-hydroxy pyrimidine-2-carboxylic acid SHANGHAI BEPHARM CO., LTD. (CN) 2016-02-24 CN disclosed
CN-103880757-B A kind of synthetic method of 5-hydroxy pyrimidine-2-carboxylic acid SHANGHAI BEPHARM CO., LTD. (CN) 2016-02-24 CN disclosed
CN-103880757-A Synthesis method for 5-hydroxyl pyrimidine-2-carboxylic acid BIDE PHARMATECH LTD 2014-06-25 CN disclosed
CN-103880757-A Synthesis method for 5-hydroxyl pyrimidine-2-carboxylic acid BIDE PHARMATECH LTD 2014-06-25 CN disclosed
CN-103880757-A Synthesis method for 5-hydroxyl pyrimidine-2-carboxylic acid BIDE PHARMATECH LTD 2014-06-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260001994-A1 HIGH-MOLECULAR COMPOUND, MOLDING COMPOSITION, FILM AND CAPACITOR CCRL2, CBR1, CCR1 CA12 648/4885CA1 887/4885CA2 450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.